who should not take glp-1 receptor agonists – Peripheral Brain GLP-1 Medications for Weight Loss:

Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases

In support of this, numerous epidemiological studies including European paradox study (Bellizzi et al., 1994), WHO/MONICA study (Gey and Puska, 1989), NHS study (Stampfer et al., 1993), and Harvard HPSF (Rimm et al., 1993) have shown that antioxidant was negatively associated with many NCDs including cardiovascular diseases

Kong YX, Li ZS, Liu YB, Pan B, Fu X, Xiao R, et al

Glucaric acid and ribonic acid had the most significant positive correlation with each other, and there were also highly positive correlations between L-acetylcarnitine and L-carnitine, and between taurine and glutathione (Table 3)